Tissue Maturation is a crucial phase in the development of engineered tissues, wherein the created constructs evolve to exhibit characteristics akin to natural, mature tissues. This process involves the refinement of cellular organization, extracellular matrix composition, and functional properties to achieve optimal performance and integration within the host organism. During tissue maturation, cells within the construct undergo differentiation, adopting specialized functions relevant to the targeted tissue type. The extracellular matrix undergoes remodeling, with the deposition and alignment of structural proteins contributing to the biomechanical strength and integrity of the tissue. Factors such as nutrient supply, oxygenation, and mechanical cues play pivotal roles in guiding tissue maturation. Bioreactors and perfusion systems are often employed to simulate physiological conditions, providing a conducive environment for cells to mature and organize appropriately. Monitoring techniques, including imaging, histological analyses, and functional assessments, are crucial for evaluating the degree of tissue maturation. Successful tissue maturation is paramount for the clinical efficacy of engineered tissues, ensuring their seamless integration, functionality, and long-term stability within the host. Ongoing research in tissue engineering emphasizes strategies and technologies to enhance the maturation process, contributing to advancements in regenerative medicine and the development of more sophisticated tissue-engineered constructs.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy